Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Virpax Pharmaceuticals Inc (VRPX)

Virpax Pharmaceuticals Inc (VRPX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 54,826
  • Shares Outstanding, K 11,715
  • Annual Sales, $ 0 K
  • Annual Income, $ -4,340 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.18
Trade VRPX with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.76 +21.18%
on 11/10/21
4.95 -7.95%
on 11/30/21
+0.33 (+7.72%)
since 11/01/21
3-Month
3.76 +21.18%
on 11/10/21
19.36 -76.46%
on 09/03/21
-13.75 (-75.12%)
since 09/01/21

Most Recent Stories

More News
Virpax Pharmaceuticals Reports 2021 Third Quarter Results and Recent Developments

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the three and nine months ended September 30, 2021, and other recent developments....

VRPX : 4.66 (-0.43%)
Virpax Advances Envelta™ Development with NCATS Under CRADA Agreement

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications,...

VRPX : 4.66 (-0.43%)
Virpax Signs Agreement with Sinclair Research to Initiate Investigational New Drug (IND)-Enabling Studies for AnQlar™

Virpax ® Pharmaceuticals Inc. ("Virpax" or the "Company") (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed...

VRPX : 4.66 (-0.43%)
Virpax to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com on October 7, 2021

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications,...

VRPX : 4.66 (-0.43%)
Virpax to Present at the NobleCon Online Pain Management Investor Forum on Channelchek.com on October 7, 2021

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications,...

VRPX : 4.66 (-0.43%)
Virpax to Develop Intranasal Cannabidiol Product for the Management of Epilepsy in Adults and Children

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications,...

VRPX : 4.66 (-0.43%)
Virpax® Pharmaceuticals Announces Closing of $40 Million Public Offering of Common Stock

Virpax ® Pharmaceuticals Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the closing of an underwritten...

VRPX : 4.66 (-0.43%)
Virpax® Pharmaceuticals Announces Pricing of $40 Million Public Offering of Common Stock

Virpax ® Pharmaceuticals Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing pharmaceutical products for pain management, today announced the pricing of an underwritten...

VRPX : 4.66 (-0.43%)
Virpax Pharmaceuticals Announces Poster Presentation for Envelta™ at PAINWeek 2021

Virpax ® Pharmaceuticals, Inc. (“Virpax” or the “Company”) (NASDAQ:VRPX), today announced it will present a poster on Leucine Enkephalin as a potential analgesic at PAINWeek 2021, being held...

VRPX : 4.66 (-0.43%)
Virpax Announces MMS019 Manufacturing and Supply Agreement

Virpax ® Pharmaceuticals, Inc. ("Virpax" or the "Company") (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS and anti-viral indications, today announced...

VRPX : 4.66 (-0.43%)

Business Summary

Virpax Pharmaceuticals Inc. is a preclinical stage biopharmaceutical company. It is focused on pain management by developing and delivering non-opioid and non-addictive pharmaceutical products using new drug delivery systems and technology. Virpax Pharmaceuticals Inc. is based in WEST CHESTER, PA.

See More

Key Turning Points

3rd Resistance Point 6.00
2nd Resistance Point 5.47
1st Resistance Point 5.08
Last Price 4.66
1st Support Level 4.16
2nd Support Level 3.63
3rd Support Level 3.24

See More

52-Week High 36.00
Fibonacci 61.8% 23.66
Fibonacci 50% 19.85
Fibonacci 38.2% 16.04
Last Price 4.66
52-Week Low 3.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar